Publications

The Annals of otology, rhinology, and laryngology

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

01-06-2026

Journal of cancer survivorship : research and practice

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

01-06-2026

ESMO real world data and digital oncology

Validating large language model-assisted data extraction from clinical notes.

01-06-2026

PloS one

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

01-06-2026

Academic radiology

CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

01-06-2026

Nature

Pervasive and programmed nucleosome distortion on single chromatin fibres.

01-06-2026

Cancer discovery

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

01-06-2026

Genes & development

Cohesin-mediated loop extrusion and enhancer-associated factors additively contribute to Sox2 looping with its distal enhancer.

01-06-2026

European radiology

Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.

01-06-2026

Cancer research

Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.

01-06-2026

Blood

DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

29-05-2026

Journal of robotic surgery

Eye-hand coordination during robotic prostate cancer surgery - how surgical vision reflects on instrument kinematics and vice versa.

28-05-2026

Cancer communications (London, England)

Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

25-05-2026

Scientific reports

Explainable machine learning identifies features and thresholds predictive of immunotherapy response.

23-05-2026

Cancer chemotherapy and pharmacology

Transfer of trastuzumab and pertuzumab into human breast milk: a case report.

20-05-2026

Nature communications

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

19-05-2026

European radiology

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size.

16-05-2026

BMC cancer

Hepatic arterial infusion pump chemotherapy combined with systemic therapy versus systemic therapy alone as induction treatment for initially unresectable colorectal liver metastases: a study protocol of the randomised controlled trial - PUMP-IT RCT.

16-05-2026

European journal of cancer (Oxford, England : 1990)

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy.

15-05-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

15-05-2026

European radiology experimental

MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.

13-05-2026

Journal for immunotherapy of cancer

Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

13-05-2026

Cancer discovery

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

13-05-2026

Proceedings of the National Academy of Sciences of the United States of America

Acupuncture does not work and has no place in science-based medicine.

12-05-2026

Nature communications

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

12-05-2026

Scientific reports

Crowdsourcing enables robust cell annotation for breast cancer pathology.

11-05-2026

Genome medicine

The contribution of rare germline variants to the immune landscape of breast cancer.

09-05-2026

Cancers

Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort.

08-05-2026

BMJ open

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.

07-05-2026

NPJ breast cancer

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

06-05-2026

Breast cancer research and treatment

Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?

05-05-2026

Journal of cancer survivorship : research and practice

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.

05-05-2026

Current oncology (Toronto, Ont.)

Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study.

05-05-2026

BMJ open

Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study.

04-05-2026

European journal of cancer (Oxford, England : 1990)

BRAF^V600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.

02-05-2026

European journal of cancer (Oxford, England : 1990)

The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit).

02-05-2026

FEBS open bio

Optimizing photoactivation of PA-mCherry for optical pooled CRISPR screens.

01-05-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

01-05-2026

Annals of surgical oncology

ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

01-05-2026

Trends in cancer

FGFR rearrangements: oncogenic drivers and therapeutic targets.

01-05-2026

Physics and imaging in radiation oncology

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

01-05-2026

The Lancet regional health. Europe

Advances in cell therapy for solid tumours: European perspective and future directions.

01-05-2026

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Health-related quality of life and functional outcomes of colon cancer patients in the Netherlands: A population-based study.

01-05-2026

International journal of radiation oncology, biology, physics

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.

01-05-2026

Clinical and translational radiation oncology

ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer.

01-05-2026

Physics and imaging in radiation oncology

Clinical feasibility of fast adaptive four-dimensional cone-beam computed tomography for lung cancer radiotherapy.

01-05-2026

European urology

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

01-05-2026

Clinical pharmacokinetics

Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours.

01-05-2026

Nature

Prospective evaluation of genomics-guided off-label treatment.

01-05-2026

Nature protocols

Inducible CRISPR-Cas9 screening platform to interrogate non-proliferative cellular states.

01-05-2026

A Prospective Multicenter Observational Study Investigating the Concordance Between Patient-Reported Hearing Loss and Commonly Used Ototoxicity Grading Systems in Patients Treated with Platinum-Based Chemotherapy.

Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment.

Validating large language model-assisted data extraction from clinical notes.

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE.

CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

Pervasive and programmed nucleosome distortion on single chromatin fibres.

Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Cohesin-mediated loop extrusion and enhancer-associated factors additively contribute to Sox2 looping with its distal enhancer.

Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validation.

Targeting the Non-Homologous End Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated Senescence.

DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

Eye-hand coordination during robotic prostate cancer surgery - how surgical vision reflects on instrument kinematics and vice versa.

Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

Explainable machine learning identifies features and thresholds predictive of immunotherapy response.

Transfer of trastuzumab and pertuzumab into human breast milk: a case report.

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size.

Hepatic arterial infusion pump chemotherapy combined with systemic therapy versus systemic therapy alone as induction treatment for initially unresectable colorectal liver metastases: a study protocol of the randomised controlled trial - PUMP-IT RCT.

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy.

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.

Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Acupuncture does not work and has no place in science-based medicine.

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

Crowdsourcing enables robust cell annotation for breast cancer pathology.

The contribution of rare germline variants to the immune landscape of breast cancer.

Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort.

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.

Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study.

Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study.

BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.

The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit).

Optimizing photoactivation of PA-mCherry for optical pooled CRISPR screens.

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

FGFR rearrangements: oncogenic drivers and therapeutic targets.

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

Advances in cell therapy for solid tumours: European perspective and future directions.

Health-related quality of life and functional outcomes of colon cancer patients in the Netherlands: A population-based study.

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.

ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer.

Clinical feasibility of fast adaptive four-dimensional cone-beam computed tomography for lung cancer radiotherapy.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours.

Prospective evaluation of genomics-guided off-label treatment.

Inducible CRISPR-Cas9 screening platform to interrogate non-proliferative cellular states.

This site uses cookies

BRAF^V600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.